Having shown bioactivity equivalent to native FGF21 in mouse 3T3-L1 cells, LY2405319 action was next evaluated in HepG2 hepatoma cells that are of human origin and endogenously express Klb and FGFRs [27], [28]. The gene discussed is KLB; the disease is hepatocellular carcinoma.